Litcius/Paper detail

Clinical safety of daridorexant in insomnia treatment: Analysis of FDA adverse event reports

Qi Wang, Qin Zhou, Zhiqiang Du, Rongrong Lu, Ying Jiang, Haohao Zhu

2024Journal of Affective Disorders13 citationsDOI

Topics & Concepts

Adverse Event Reporting SystemAdverse effectMedicineInsomniaSafety profileOrexin receptorPharmacologyInternal medicineOrexinNeuropeptideReceptorSleep and Wakefulness ResearchSleep and related disordersRestless Legs Syndrome Research
Clinical safety of daridorexant in insomnia treatment: Analysis of FDA adverse event reports | Litcius